Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab

被引:30
作者
Button, Tom [1 ]
Altmann, Dan [2 ]
Tozer, Dan [3 ]
Dalton, Catherine [3 ]
Hunter, Kelvin [3 ]
Compston, Alastair [1 ]
Coles, Alasdair [1 ]
Miller, David [3 ]
机构
[1] Univ Cambridge, Cambridge CB2 2QQ, England
[2] London Sch Hyg & Trop Med, London WC1, England
[3] UCL Inst Neurol, London, England
关键词
magnetization transfer; multiple sclerosis; alemtuzumab;
D O I
10.1177/1352458512444915
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
The magnetization transfer ratio reflects the integrity of tissue structure, including myelination and axonal density. Mean magnetization transfer ratio fell in 18 untreated patients with multiple sclerosis both in normal appearing grey (-0.25 pu/year, p < 0.001) and white matter (-0.12 pu/year, p = 0.004). Conversely, mean magnetization transfer ratio was stable in 20 alemtuzumab-treated patients (grey matter: -0.01 pu/year, p = 0.87; white matter: -0.02 pu/year, p = 0.51). The gradient difference in grey matter was 0.25 pu/year < 0.001) after age-adjustment. These data suggest that in multiple sclerosis alemtuzumab protects against tissue damage in normal-appearing grey matter, perhaps by preventing new lesion formation.
引用
收藏
页码:241 / 244
页数:4
相关论文
共 10 条
[1]
Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis [J].
Agosta, Federica ;
Rovaris, Marco ;
Pagani, Elisabetta ;
Sormani, Maria Pia ;
Comi, Giancarlo ;
Filippi, Massimo .
BRAIN, 2006, 129 :2620-2627
[2]
An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio [J].
Barker, GJ ;
Tofts, PS ;
Gass, A .
MAGNETIC RESONANCE IMAGING, 1996, 14 (04) :403-411
[3]
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials [J].
Barkhof, Frederik ;
Calabresi, Peter A. ;
Miller, David H. ;
Reingold, Stephen C. .
NATURE REVIEWS NEUROLOGY, 2009, 5 (05) :256-266
[4]
Cortical Pathology in RRMS: Taking a Cue from Four Sisters [J].
Calabrese, Massimiliano ;
Seppi, Dario ;
Cocco, Eleonora ;
Poretto, Valentina ;
Rinaldi, Francesca ;
Perini, Paola ;
Gallo, Paolo .
MULTIPLE SCLEROSIS INTERNATIONAL, 2012, 2012
[5]
Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670
[6]
Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis [J].
Cox, AL ;
Thompson, SAJ ;
Jones, JL ;
Robertson, VH ;
Haley, G ;
Waldmann, H ;
Compston, DAS ;
Coles, AJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (11) :3332-3342
[7]
Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis [J].
Davies, GR ;
Altmann, DR ;
Hadjiprocopis, A ;
Rashid, W ;
Chard, DT ;
Griffin, CM ;
Tofts, PS ;
Barker, GJ ;
Kapoor, R ;
Thompson, AJ ;
Miller, DH .
JOURNAL OF NEUROLOGY, 2005, 252 (09) :1037-1044
[8]
Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity [J].
Jones, Joanne L. ;
Anderson, Jane M. ;
Phuah, Chia-Ling ;
Fox, Edward J. ;
Selmaj, Krzysztof ;
Margolin, David ;
Lake, Stephen L. ;
Palmer, Jeffrey ;
Thompson, Sara J. ;
Wilkins, Alastair ;
Webber, Daniel J. ;
Compston, D. Alastair ;
Coles, Alasdair J. .
BRAIN, 2010, 133 :2232-2247
[9]
Cortical demyelination and diffuse white matter injury in multiple sclerosis [J].
Kutzelnigg, A ;
Lucchinetti, CF ;
Stadelmann, C ;
Brück, W ;
Rauschka, H ;
Bergmann, M ;
Schmidbauer, M ;
Parisi, JE ;
Lassmann, H .
BRAIN, 2005, 128 :2705-2712
[10]
Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain [J].
Schmierer, Klaus ;
Tozer, Daniel J. ;
Scaravilli, Francesco ;
Altmann, Daniel R. ;
Barker, Gareth J. ;
Tofts, Paul S. ;
Miller, David H. .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2007, 26 (01) :41-51